Developmental docosahexaenoic and arachidonic acid supplementation improves adult learning and increases resistance against excitotoxicity in the brain

Acta Physiologica Hungarica

Volumn 100, Issue 2, 2013, Pages 186-196

  Godor Kacsandi A ^a   Felszeghy, K ^a   Ranky, M ^a   Luiten, P ^b   Nyakas, Csaba ^a,b  

^a SEMMELWEIS UNIVERSITY   (Hungary)

^b UNIVERSITY OF GRONINGEN   (Netherlands)

Author keywords

brain development; excitotoxic lesion; LC PUFA; learning; neuroprotection

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID;

ARTICLE; EXCITOTOXICITY; LEARNING; SUPPLEMENTATION;

ANIMALS; ARACHIDONIC ACID; DIETARY SUPPLEMENTS; DOCOSAHEXAENOIC ACIDS; DRUG EVALUATION, PRECLINICAL; ENTORHINAL CORTEX; FEMALE; MAZE LEARNING; MEMORY; MEMORY DISORDERS; MICROGLIA; N-METHYLASPARTATE; PREGNANCY; RATS; RATS, WISTAR;

EID: 84878497207     PISSN: 0231424X     EISSN: 15882683     Source Type: Journal    
DOI: 10.1556/APhysiol.100.2013.005     Document Type: Article

References (42)

1. Agostoni C: Docosahexaenoic acid (DHA): from the maternal-foetal dyad to the complementary feeding period. Early Hum. Dev. 86, 3-6 (2010)
2. Ando S, Kobayashi S, Waki H, Kon K, Fukui F, Tadenuma T, Iwamoto M, Takeda Y, Izumiyama N, Watanabe K, Nakamura H: Animal model of dementia induced by entorhinal synaptic damage and partial restoration of cognitive deficits by BDNF and carnitine. J. Res. 70, 519-527 (2002) (Pubitemid 35222389)
3. Barcelo-Coblijn G, Hõgyes E, Kitajka K, Puskás LG, Zvara A, Hackler L Jr, Nyakas C, Penke Z, Farkas T: Modification by docosahexaenoic acid of age-induced alterations in gene expression and molecular composition of rat brain phospholipids. Proc. Natl Acad. Sci. USA 100, 11321-11326 (2003) (Pubitemid 37205933)
4. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson JS: Fetal nutrition and cardiovascular disease in adult life. Lancet 341, 938-941 (1993) (Pubitemid 23109122)
5. Bazan NG, Molina MF, Gordon WC: Docosahexaenoic acid signalolipidomics in nutrition: significance in aging, neuroinflammation, macular degeneration, Alzheimer's, and other neurodegenerative diseases. Annu. Rev. Nutr. 31, 321-51 (2011)
6. Bourre JM, Francois M, Youyou A, Dumont O, Piciotti M, Pascal G, Durand G: The effects of dietary alphalinolenic acid on the composition of nerve membranes, enzymatic activity, amplitude of electrophysiological parameters, resistance to poisons and performance of learning tasks in rats. J. Nutr. 119, 1880-1892 (1989) (Pubitemid 20063881)
7. Carlson SE, Werkman SH, Peeples JM, Wilson WM: Long-chain fatty acids and early visual and cognitive development of preterm infants. Eur. J. Clin. Nutr. 48, S27-S30 (1994) (Pubitemid 24245238)
8. Carlson SE: Docosahexaenoic acid supplementation in pregnancy and lactation. Am. J. Clin. Nutr. 89, 678S-684S (2009)
9. Coutureau E, Di Scala G: Entorhinal cortex and cognition. Prog. Neuropsychopharmacol. Biol. Psychiatry 33, 753-761 (2009)
10. Deckelbaum RJ, Worgall TS, Seo T: n-3 fatty acids and gene expression. Am. J. Clin. Nutr. 83, 1520S-1525S (2006) (Pubitemid 44713093)
11. Dunstan JA, Simmer K, Dixon G, Prescott SL: Cognitive assessment of children at age 2(1/2) years after maternal fish oil supplementation in pregnancy: a randomised controlled trial. Arch. Dis. Child Fetal Neonatal Ed. 93, F45-F50 (2008)
12. Eichenbaum H, Lipton PA: Towards a functional organization of the medial temporal lobe memory system: role of the parahippocampal and medial entorhinal cortical areas. Hippocampus 18, 1314-1324 (2008)
13. Farquharson J, Jamieson EC, Abbasi KA, Patrick WJA, Logan RW, Cockburn F: Effect of diet on the fatty acid composition of the major phospholipids of infant cerebral cortex. Arch. Dis. Child. 72, 198-203 (1995)
14. Fewtrell MS, Abbott RA, Kennedy K, Singhal A, Morley R, Caine E, Jamieson C, Cockburn F, Lucas A: Randomized, double-blind trial of long-chain polyunsaturated fatty acid supplementation with fish oil and borage oil in preterm infants. J. Pediatr. 144, 471-479 (2004) (Pubitemid 38457350)
15. Fleith M, Clandinin MT: Dietary PUFA for preterm and term infants: review of clinical studies. Crit. Rev. Food Sci. Nutr. 45, 205-229 (2005) (Pubitemid 41657357)
16. Gamoh S, Hashimoto M, Hossain S, Masumura S: Chronic administration of docosahexaenoic acid improves the performance of radial arm maze task in aged rats. Clin. Exp. Pharmacol. Physiol. 28, 266-270 (2001) (Pubitemid 32250711)
17. Guo F, Jen KLC: High-fat feeding during pregnancy and lactation affects offspring metabolism in rats. Physiol. Behav. 57, 681-686 (1995)
18. Hadders-Algra M: Prenatal and early postnatal supplementation with long-chain polyunsaturated fatty acids: neurodevelopmental considerations. Am. J. Clin. Nutr. 94, 1874S-1879S (2011)
19. Hashimoto M, Hossain S, Shimada T, Sugioka K, Yamasaki H, Fujii Y, Ishibashi Y, Oka J, Shido O: Docosahexaenoic acid provides protection from impairment of learning ability in Alzheimer's disease model rats. J. Neurochem. 81, 1084-1091 (2002) (Pubitemid 34809291)
20. Helland IB, Smith L, Saarem K, Saugstad OD, Drevon CA: Maternal supplementation with very-long-chain n-3 fatty acids during pregnancy and lactation augments children's IQ at 4 years of age. Pediatrics 111, e39-e44 (2003)
21. Hõgyes E, Nyakas C, Kiliaan A, Farkas T, Penke B, Luiten PGM: Neuroprotective effect of developmental docosahexaenoic acid supplement against excitotoxic brain damage in infant rats. Neuroscience 119, 999-1012 (2003) (Pubitemid 36776450)
22. Holman RT: The slow discovery of the importance of ù3 essential fatty acids in human brain. J. Nutr.128, 427S-433S (1998) (Pubitemid 28090397)
23. Horrocks LA, Yeo YK: Health benefits of docosahexaenoic acid (DHA). Pharmacol. Res. 40, 211-225 (1999) (Pubitemid 29435720)
24. Ikemoto A, Nitta A, Furukawa S, Ohishi M, Nakamura A, Fujii Y, Okuyama H: Dietary n-3 fatty acid deficiency decreases nerve growth factor content in rat hippocampus. Neurosci. Lett. 285, 99-102 (2000) (Pubitemid 30227629)
25. Jo YS, Lee I: Disconnection of the hippocampal-perirhinal cortical circuits severely disrupts object-place paired associative memory. J. Neurosci. 30, 9850-9858 (2010)
26. Kuipers RS, Luxwolda MF, Sango WS, Kwesigabo G, Dijck-Brouwer DA, Muskiet FA: Maternal DHA equilibrium during pregnancy and lactation is reached at an erythrocyte DHA content of 8 g/100 g fatty acids. J. Nutr. 141, 418-427 (2011)
27. Kurlak LO, Stephenson TJ: Plausible explanations for effects of long chain polyunsaturated fatty acids (LCPUFA) on neonates. Arch. Dis. Child. Fetal Neonatal Ed. 80, F148-F154 (1999) (Pubitemid 29122220)
28. Lim SY, Hoshiba J, Salem N Jr: An extraordinary degree of structural specificity is required in neural phospholipids for optimal brain function: n-6 docosapentaenoic acid substitution for docosahexaenoic acid leads to a loss in spatial task performance. J. Neurochem. 95, 848-857 (2005) (Pubitemid 41567175)
29. Makrides M, Collins CT, Gibson RA: Impact of fatty acid status on growth and neurobehavioural development in humans. Matern. Child. Nutr. 7, 80-88 (2011)
30. Meck WH, Williams CL: Metabolic imprinting of choline by its availability during gestation: implications for memory and attentional processing across the lifespan. Neurosci. Biobehav. Rev. 27, 385-399 (2003) (Pubitemid 36999837)
31. Morris R: Developments of a water-maze procedure for studying spatial learning in the rat. J. Neurosci. Methods 11, 47-60 (1984) (Pubitemid 14088970)
32. Nouvelot A, Delbart C, Bourre JM: Hepatic metabolism of dietary alpha-linolenic acid in suckling rats, and its possible importance in polyunsaturated fatty acid uptake by the brain. Ann. Nutr. Metab. 30, 316-323 (1986) (Pubitemid 16073737)
33. Nyakas C, Felszeghy K, Szabó R, Keijser JN, Luiten PG, Szombathelyi Z, Tihanyi K: Neuroprotective effects of vinpocetine and its major metabolite cis-apovincaminic acid on NMDA-induced neurotoxicity in a rat entorhinal cortex lesion model. CNS Neurosci. Ther. 15, 89-99 (2009)
34. Paxinos G, Watson G (1982): The rat brain in stereotaxic coordinates. Academic Press, Sydney.)
35. Rapoport SI, Ramadan E, Basselin M: Docosahexaenoic acid (DHA) incorporation into the brain from plasma, as an in vivo biomarker of brain DHA metabolism and neurotransmission. Prostaglandins Other Lipid Mediat. 96, 109-113 (2011)
36. Salem N, Niebylski CD: The nervous system has absolute molecular species requirement for proper function. Molec. Membr. Biol. 12, 131-134 (1995)
37. Uauy R, Mena P: Lipids and neurodevelopement. Nutr. Rev. 59, S34-S46 (2001)
38. Van Dijk G, Kacsándi A, Kóbor-Nyakas DE, Hogyes E, Nyakas C: Perinatal polyunstaurated fatty acids supplementation causes alterations in fuel homeostasis in adult male rats but does not offer resistance against STZ-induced diabetes. Horm. Metab. Res. 43, 938-943 (2011)
39. Van Goor SA, Dijck-Brouwer DA, Erwich JJ, Schaafsma A, Hadders-Algra M: The influence of supplemental docosahexaenoic and arachidonic acids during pregnancy and lactation on neurodevelopment at eighteen months. Prostaglandins Leukot. Essent. Fatty Acids 84, 139-146 (2011)
40. Wainwright PE: Dietary essential fatty acids and brain function: a developmental perspective on mechanisms. Proc. Nutr. Soc. 61, 61-69 (2002) (Pubitemid 34171047)
41. Yang X, Sheng W, Sun GY, Lee JC: Effects of fatty acid unsaturation numbers on membrane fluidity and á-secretase-dependent amyloid precursor protein processing. Neurochem. Int. 58, 321-329 (2011)
42. Yehuda S, Rabinovitz S, Mostofsky DI: Essential fatty acids are mediators of brain biochemistry and cognitive functions. J. Neurosci. Res. 56, 565-570 (1999) (Pubitemid 29246838)